NCT05819502View on ClinicalTrials.gov

"Profile HIT (Holistic Individualized Treatment)"

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

February 24, 2024

Study Completion Date

March 24, 2024

Conditions
Aesthetic
Interventions
DRUG

Restylane line of injectables

Restylane fillers are manufactured by Q-Med AB, part of the Galderma Group.

Trial Locations (1)

H3R 3A1

Erevna Innovations Inc, Montreal

Sponsors
All Listed Sponsors
lead

Erevna Innovations Inc.

OTHER